According to an advance edition of the New England Journal of Medicine, a new type of medicine for type 1 diabetes could prove effective. The new treatment, administered by injectio, is called GAD-alum.
GAD-alum specifically targets an individual protein called GAD. Amongst people with type 1 diabetes, GAD is part of the way in which the immune system attacks the pancreas . By curbing GAD, researcher believe the insulin -producing cells in the pancreas could be saved.
A study conducted in Sweden at Linkoping University tested GAD-alum treatment and found that whilst it did not cure type 1 diabetes, the rate of decline in pancreatic cells slowed somewhat. Although GAD-alum testing appears safe, the researchers noted that further research was needed. The study was done using grants from Diamyd Medical .

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Type 2 diabetes found to be a ‘significant risk factor’ among stroke victims

More evidence has been published which supports that diabetes is a “significant…

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…